Division Of Outcomes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
SPPS showcases educational and intellectual innovation at AACP Annual Meeting - UBNow: News and views for UB faculty and staff
buffalo.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from buffalo.edu Daily Mail and Mail on Sunday newspapers.
Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients
Researchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model to help clinicians predict the risk of death within 40 days in patients who are hospitalized with COVID-19 infection.
A new paper describing this retrospective, observational, multicenter cohort analysis, Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19, was recently published in
PLOS ONE, a peer-reviewed, open-access scientific journal.
The model considers six risk factors: age, respiratory and oxygenation rates, and preexisting conditions such as high blood pressure, coronary artery disease, or chronic kidney disease that play a role in COVID-19 deaths. Older age was determined to be the strongest predictor of death, according to health records of patients who were hospitalized with COVI
A new Hackensack Meridian Health study shows that people with mild symptoms of COVID-19 may be helped by a controversial drug that had been widely used in the early days of the pandemic before several studies questioned its benefits and safety.
The recently published study looked at a group of people treated as outpatients last year and found that those who received an anti-inflammatory drug, hydroxychloroquine, which is often used for malaria, were significantly less likely to end up in the hospital. Doctors who conducted the study say the findings suggest that it should be tested further. We make it clear we can t recommend it to be given, said Andrew Ip, a lymphoma physician and director of the Division of Outcomes and Value Research at the